ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.896,50
-0,14%
S&P 500
5.036,38
0,36%
Dow Jones
38.049,82
0,39%
Euro vs US Dollar
1,07073
-0,10%
Bitcoin
59.013,96
1,33%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Acadia Pharmaceuticals Inc (ACAD)

  7. Acadia Pharmaceuticals Inc (ACAD) News

ACAD Acadia Pharmaceuticals Inc

17,28
0,23 (1,35%)
Zuletzt aktualisiert: 18:26:06
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Acadia Pharmaceuticals Inc ACAD NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,23 1,35% 17,28 18:26:06
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
16,94 16,81 17,33 17,05
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.4.202422:16BWAcadia Pharmaceuticals is Proud to Announce the Winners of..
24.4.202422:05BWAcadia Pharmaceuticals to Announce First Quarter Financial..
22.4.202415:04BWAcadia Pharmaceuticals Announces Trofinetide New Drug..
19.4.202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
17.4.202422:05BWAcadia Pharmaceuticals Presents New DAYBUE™ (trofinetide)..
02.4.202422:05BWAcadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive..
01.4.202422:05BWAcadia Pharmaceuticals to Participate in the 23rd Annual..
15.3.202421:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
13.3.202421:05BWAcadia Pharmaceuticals to Participate in the UBS Virtual CNS..
12.3.202412:21IHMARKETNEWSOracle Soars 13% With Exceptional Growth and Boosts Nvidia..
11.3.202421:05EDGAR2Form 8-K - Current report
11.3.202421:05BWAcadia Pharmaceuticals Announces Top-Line Results from Phase..
29.2.202415:05BWAcadia Pharmaceuticals to Participate in TD Cowen’s 44th..
28.2.202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:16EDGAR2Form 8-K - Current report
27.2.202422:05BWAcadia Pharmaceuticals Reports Fourth Quarter and Full Year..
21.2.202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
14.2.202413:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13.2.202422:05BWAcadia Pharmaceuticals to Announce Fourth Quarter and Full..
08.2.202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202423:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
31.1.202403:55EDGAR2Form 8-K - Current report
31.1.202402:48BWAcadia Announces Additions to Executive Team
26.1.202423:25EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19.1.202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
18.1.202422:05BWAcadia Announces the Passing of Former President Srdjan..
10.1.202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202322:05BWAcadia Pharmaceuticals to Present at the 42nd Annual J.P...
18.12.202322:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
16.12.202301:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202318:46EDGAR2Form 144 - Report of proposed sale of securities
14.12.202311:59IHMARKETNEWSApple Stocks Reach Record, Adobe Faces Stock Drops,..
14.12.202303:24BWDelaware District Court Rules in Favor of Acadia on..
13.12.202319:41BWDelaware Federal District Court Rules in Favor of Acadia..
30.11.202315:05BWAcadia Pharmaceuticals Initiates Pivotal Phase 3 Study of..
28.11.202323:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.11.202315:05BWAcadia Pharmaceuticals Initiates Phase 2 Clinical Trial of..
22.11.202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.11.202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.11.202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202323:11EDGAR2Form 8-K - Current report
21.11.202323:00BWAcadia Pharmaceuticals Announces Change in Research and..
14.11.202322:12BWAcadia Pharmaceuticals Reports Inducement Grants Under..
02.11.202321:21EDGAR2Form 8-K - Current report
02.11.202321:05BWAcadia Pharmaceuticals Reports Third Quarter 2023 Financial..

Kürzlich von Ihnen besucht

NASDAQ
ACAD
Acadia Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten